Biodistribution Study of Pantoprazole Sodium in Rodent Tissues: A Tool for Pharmacokinetic Study
Abstract
Background: Pantoprazole sodium is one of the most widely used drugs for treating gastric acid– related disorders as well as is the most popular drug among various cancer therapy protocols for treating gastric disturbances pertained to the chemotherapy. The present study aims to validate high-performance liquid chromatographic (HPLC) method for the quantification of pantoprazole sodium in mice plasma and various tissue homogenates including kidney, heart, prostate, lung, pancreas, liver, and brain. Pantoprazole sodium estimation was done using 100 μL aliquot, which was injected into HPLC system, and the separation was achieved using Shimadzu C18 column at 40°C. Mobile phase composed of acetonitrile/dibasic phosphate buffer (40:60, v/v), pH = 7.4 was isocratically pumped at 1.0 mL min-1, and detection was performed at wavelength of 290 nm.
Material and Methods: All the samples including tissues and plasma were collected after 4 h of oral administration of pantoprazole sodium to Swiss albino mice (10 mg/kg, p.o.).
Results: Bioanalytical method was further validated according to the standard guidelines and portrays to be selective as well as linear (r2 ≥ 0.999) over the concentration range of 10–50 ng/injection. The intraday (% relative standard deviation [RSD] = 0.29%–1.21%) and inter-day precision (%RSD = 0.52%–2.88%) was found to be within the layout standards by International Council for Harmonization. Pantoprazole sodium extraction recovery was achieved between 64.15% and 78.17% demonstrating the suitability of the method.
Conclusion: Bio-distribution study so carried out by bioanalytical technique can be used as an aiding tool for the quantification of pantoprazole sodium in all the studies involving the pharmacokinetic profiling of drug in various tissues of rodents.
Highlights
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Simultaneous Determination of Isoniazid, Pyrazinamide and Rifampin in Human Plasma by High-performance Liquid Chromatography and UV Detection
Dasht Bozorg B, Goodarzi A, Fahimi F, Tabarsi P, Shahsavari N, et al. Simultaneous Determination of Isoniazid, Pyrazinamide and Rifampin in Human Plasma by High-performance Liquid Chromatography and UV Detection. Iran J Pharm Res. 2019;18(4):e124712. doi: https://doi.org/10.22037/ijpr.2019.1100849
Assay of Pyrantel Pamoate Using Iron (III) Chloride and Three Complexing Agents by Spectrophotometry
Swamy N, Basavaiah K. Assay of Pyrantel Pamoate Using Iron (III) Chloride and Three Complexing Agents by Spectrophotometry. J Rep Pharm Sci. 2015;4(2):e147675. doi:
A Rapid, Simple, Liquid Chromatographic-Electrospray Ionization, Ion Trap Mass Spectrometry Method for the Determination of Finasteride in Human Plasma and its Application to Pharmacokinetic Study
Hashemi Mousavi SH, Kobarfard F, Husain SW, Tehrani MS, Abroomand Azar P, et al. A Rapid, Simple, Liquid Chromatographic-Electrospray Ionization, Ion Trap Mass Spectrometry Method for the Determination of Finasteride in Human Plasma and its Application to Pharmacokinetic Study. Iran J Pharm Res. 2012;11(1):e125790. doi: https://doi.org/10.22037/ijpr.2012.1063
Rapid High Performance Liquid Chromatographic Determination of Risperidone in Human Plasma
Foroutan SM, Zarghi A, Shafaati A, Khoddam A. Rapid High Performance Liquid Chromatographic Determination of Risperidone in Human Plasma. Iran J Pharm Res. 2022;5(1):e128260. doi: https://doi.org/10.22037/ijpr.2010.650
Pharmacokinetics and Bioequivalence of Two Formulations of Apixaban Tablets: A Double-Blind, Single-Dose, Crossover Study in Healthy Subjects
Abdollahizad E, Haeri A, Jouyban A, Afshar Mogaddam MR, Abbasian Z, et al. Pharmacokinetics and Bioequivalence of Two Formulations of Apixaban Tablets: A Double-Blind, Single-Dose, Crossover Study in Healthy Subjects. Iran J Pharm Res. 2025;24(1):e157714. doi: https://doi.org/10.5812/ijpr-157714
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 1 day ago
- OpenAlex: 0
Last Update: 2 days ago
- OpenCitations: 0
Last Update: 5 days ago